Argenx – Talk Bio

Actionable Insights Powered by AI

Biopharma Leaders Navigate AI ‘Hype Cycle’: Bayer, Daiichi Sankyo, and argenx Share Insights on AI Implementation in Marketing

7 months ago talkbio0Tagged Argenx, Artificial Intelligence, Bayer, Biopharma, biopharma marketing, Daiichi, Implementation, Industry, Sankyo

AI in biopharma marketing, Bayer, Daiichi Sankyo, argenx, AI implementation, biopharma industry, AI hype cycle

Argenx’s Vyvgart Hytrulo Secures Second US Approval for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

10 months ago talkbio0Tagged Approved, Argenx, Autoimmune Diseases, Peripheral Nervous System Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, United States Food and Drug Administration, Vyvgart Hytrulo

Vyvgart Hytrulo, Argenx, FDA Approval, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Autoimmune Disease, Peripheral Nervous System Disorder